NEUPOGEN

This brand name is authorized in United States. It is also authorized in Australia, Canada, Ecuador, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Israel, Lithuania, Netherlands, New Zealand, Poland, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug NEUPOGEN contains one active pharmaceutical ingredient (API):

1	Filgrastim UNII PVI5M0M1GW - FILGRASTIM
	Filgrastim causes marked increases in peripheral blood neutrophil counts within 24 hours, with minor increases in monocytes.
	Read more about Filgrastim

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NEUPOGEN Solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L03AA02	Filgrastim	L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AA Colony stimulating factors
Discover more medicines within L03AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	5741E, 5742F, 5743G, 5744H, 6126K, 6127L, 6291D, 6292E
CA	Health Products and Food Branch	01968017, 02420104, 02420112
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	01975436, 01975442, 02805914, 02805920, 03419314, 03496438, 03496444, 03976457, 05994005, 11653716, 11690255, 17668860, 17668877
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	56-MBE-0516
EE	Ravimiamet	1180134, 1180145
ES	Centro de información online de medicamentos de la AEMPS	59102, 64314, 64315
FI	Lääkealan turvallisuus- ja kehittämiskeskus	167130
FR	Base de données publique des médicaments	66663761, 66749096, 69225686
GB	Medicines & Healthcare Products Regulatory Agency	311637, 311642, 42067
HK	Department of Health Drug Office	35878, 45426, 45427
IE	Health Products Regulatory Authority	88120, 88126, 88127, 88128, 88129
IL	מִשְׂרַד הַבְּרִיאוּת	2843, 4134, 4135
LT	Valstybinė vaistų kontrolės tarnyba	1004417, 1004418, 1019797, 1019798
NL	Z-Index G-Standaard	14165082, 14681900, 14681927
NL	Z-Index G-Standaard, PRK	32557, 41831, 41858
NZ	Medicines and Medical Devices Safety Authority	11462, 11782, 6092
PL	Rejestru Produktów Leczniczych	100147295, 100147303, 100147349
SG	Health Sciences Authority	06742P, 06743P, 10780P, 10781P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699862950121, 8699862950138
US	FDA, National Drug Code	55513-209, 55513-530, 55513-546, 55513-924
ZA	Health Products Regulatory Authority	32/30.4/0032, 32/30.4/0033, Z/30.4/190